
BRASILIA, Brazil (AP) — Brazil’s former President Jair Bolsonaro was discharged from a hospital in the capital on Friday to continue serving a 27-year sentence for a coup attempt at his residence in an upscale gated community.
The Supreme Court earlier in the week granted him the right of house imprisonment due to failing health. The measure could be revised within 90 days.
Bolsonaro left the hospital DF Star in Brasilia at around 10 a.m. local time and headed to the Jardim Botanico neighborhood, where he lived prior to his conviction with his wife, Michelle Bolsonaro, and his 15-year-old daughter, Laura.
The 71-year-old was hospitalized on March 13 for pneumonia, one of several health issues he has faced since he was stabbed by a man in 2018 before being elected president. He was put in intensive care for days due to kidney and inflammatory problems.
Bolsonaro governed between 2019 and 2022 and narrowly lost his reelection bid to current President Luiz Inácio Lula da Silva.
LATEST POSTS
- 1
South Korea to End Bear Bile Farming and Find New Homes for the 200 Bears Stuck in the Industry - 2
Top 15 Web-based Entertainment Stages for Individual Marking - 3
The 1st full moon of 2026 rises tonight! Here's what to expect from January's supermoon Wolf Moon - 4
Toddler diagnosed with cancer makes remarkable recovery after aggressive treatment - 5
The Response to Independence from the rat race: Methodologies for Creating Financial momentum
Saturn's moon Titan may not have a buried ocean as long suspected, new study suggests
Instructions to Redo Your Kona SUV for Improved Tasteful Allure and Usefulness
Pick Your #1 breakfast food
Rediscovering Imagination in Adulthood: Individual Creative Excursions
Disney's latest short film 'Versa' tackles a difficult subject: Pregnancy loss. It's resonating with viewers.
Stunning new James Webb Space Telescope images reveal 'hidden' stars being born
How one man's concern saved his brothers from heart disease
The Solution to Innovative Peculiarity: Analyzing the Fate of Mankind
Judge approves Purdue Pharma’s new $7B opioid settlement with the Sacklers













